SCHEMBL27561508

SCHEMBL27561508

Cc1[nH]ccc1Nc1cccc(S(N)(=O)=O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.47
▸ TNNI3K Q59H18 2/20 0.46
▸ CA9 Q16790 6/20 0.45
▸ ROCK1 Q13464 1/20 0.45
▸ CA2 P00918 11/20 0.44
▸ CA1 P00915 10/20 0.44
▸ CA12 O43570 5/20 0.44
▸ MAPT P10636 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ GNG2 P59768 1/20 0.44
▸ GNB1 P62873 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ PHLPP2 Q6ZVD8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27576859 0.86 TNNI3K (0.45) TNNI3KALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL27561375 0.78 CA2 (0.42) TNNI3KCA9CA2CA1CA12
SCHEMBL27581881 0.77 ALDH1A1 (0.47) TNNI3KMAPTALDH1A1MAPK1
SCHEMBL27561547 0.74 RAPGEF4 (0.51) MAPTALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL27582049 0.72 AKR1C3 (0.53) —
SCHEMBL27582086 0.72 KDM4E (0.45) ALDH1A1
SCHEMBL27582099 0.72 CA2 (0.50) CA9CA2CA1CA12
SCHEMBL1765247 0.72 CA2 (0.63) POLBCA9CA2CA1CA12
SCHEMBL29899154 0.72 CA2 (0.63) POLBCA9CA2CA1CA12
SCHEMBL29932745 0.71 CA2 (0.61) POLBCA9CA2CA1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1351498-B Pyrrolotriazines inhibitors of kinases BRISTOL MYERS SQUIBB CO 2012-08-15 — — CN claimed
CN-1351498-A Pyrrolotriazines inhibitors of kinases BRISTOL MYERS SQUIBB CO (US) 2002-05-29 — — CN claimed
CN-1351498-B Pyrrolotriazines inhibitors of kinases BRISTOL MYERS SQUIBB CO 2012-08-15 — — CN disclosed
CN-1622946-A Methods of treating conditions associated with p38 kinase and pyrrolotriazine compounds useful as kinase inhibitors BRISTOL MYERS SQUIBB CO (US) 2005-06-01 — — CN disclosed
CN-1351498-A Pyrrolotriazines inhibitors of kinases BRISTOL MYERS SQUIBB CO (US) 2002-05-29 — — CN disclosed
Send feedback